Fusion IP logo

Fusion IP

Europe, Sheffield, United Kingdom, Sheffield

Description

Fusion IP owns the rights to 100% of university-owned research generated at two of the UK's leading universities.

Investor Profile

Fusion IP has made 23 investments, with 0 in the past 12 months and 9% as lead.

Stage Focus

  • Series Unknown (52%)
  • Seed (22%)
  • Grant (9%)
  • Series A (9%)
  • Undisclosed (4%)
  • Debt Financing (4%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Health Diagnostics
  • Manufacturing
  • Therapeutics
  • Semiconductor
  • Telecommunications
  • Edtech
  • Education
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fusion IP frequently co-invest with?

PU
Europe, England, United Kingdom, London
Co-Investments: 1
YFM Equity Partners
Europe, England, United Kingdom, London
Co-Investments: 1
The North West Fund
Europe, Warrington, United Kingdom, Warrington
Co-Investments: 2
Finance Yorkshire
Europe, Gloucestershire, United Kingdom, Barnsley
Co-Investments: 1
I2BF Global Ventures
North America, New York, United States, New York
Co-Investments: 1
University of Nottingham
Europe, Nottingham, United Kingdom, Nottingham
Co-Investments: 1
Development Bank of Wales
Europe, Cardiff, United Kingdom, Cardiff
Co-Investments: 6
IP Group
Europe, England, United Kingdom, London
Co-Investments: 5
SC
Europe, Leeds, United Kingdom, Leeds
Co-Investments: 3
The ERA Foundation
Europe, England, United Kingdom, London
Co-Investments: 2

Which angels does Fusion IP often collaborate with?

AB
Europe, Kingston upon Thames, United Kingdom, Kingston Upon Thames
Shared Deals: 1

What are some of recent deals done by Fusion IP?

Extraject Technology

Cardiff, Cardiff, United Kingdom

Extraject Technology is provides research and experimental development on natural sciences and engineering.

Industrial EngineeringProfessional Services
Series UnknownFeb 13, 2014
Exonate

Cambridge, Cambridgeshire, United Kingdom

Exonate is a biotech company spun out of the University of Nottingham that is focused on alternative splicing of (VEGF) in ophthalmology.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsPharmaceutical
SeedNov 3, 2013
Amount Raised: $638,210
Absynth Biologics

Sheffield, Sheffield, United Kingdom

Absynth Biologics develops treatments to prevent immunological diseases and therapies to combat bacterial infections.

BiotechnologyHealth Care
SeedJul 18, 2013
Amount Raised: $1,290,754
Magnomatics

Sheffield, Sheffield, United Kingdom

Magnomatics is a UK-based clean technology company focusing on renewable energy and energy efficiency.

EnergyHardware
Series UnknownNov 22, 2012
Amount Raised: $3,986,294
Nanotether Discovery Services

Cardiff, Cardiff, United Kingdom

Nanotether Discovery Services is a UK-based pharmaceutical research technology company developing innovative bio-chip technology.

BiopharmaBiotechnologyNanotechnologyPharmaceutical
SeedAug 20, 2012
Amount Raised: $3,455,300
MedaPhor

Cardiff, Cardiff, United Kingdom

MedaPhor - Intelligent ultrasound simulation and AI software platforms.

EdTechEducationHealth CareHealth DiagnosticsInternetMedicalMedical Device
Series UnknownAug 20, 2012
Amount Raised: $1,664,826
Phase Focus

Sheffield, Sheffield, United Kingdom

Phase Focus develops Virtual Lens, a technology that generates high definition images of an object without the need for high quality lenses.

BiotechnologyHealth Care
Series UnknownJun 29, 2012
Amount Raised: $5,000,000
Mesuro

Pencoed, Bridgend, United Kingdom

Mesuro works with companies in the RF communications field to address significant technical challenges through fundamental research.

SemiconductorTelecommunications
Series UnknownJun 21, 2012
Amount Raised: $1,094,978
Zilico

Manchester, Manchester, United Kingdom

Zilico is focused on developing next generation cancer diagnostics to provide real-time diagnosis for cervical cancer.

BiotechnologyHealth CareHealth Diagnostics
Series UnknownJun 21, 2012
Amount Raised: $1,540,791
Diurnal Group

Cardiff, Cardiff, United Kingdom

Diurnal Group is a pharmaceutical company creating therapeutic drugs used for the endocrine hormone area.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownMar 19, 2012
Amount Raised: $532,135